✦ LIBER ✦

630 POSTER Results of a phase 2 study of HGS-ETR1, a fully human agonistic monoclonal antibody to TRAIL Receptor 1, in subjects with relapsed or refractory colorectal cancer (CRC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-460 Results of a phase 2 trial of HGS-

✍ Bonomi, P.; Greco, F.; Crawford, J.; Kelly, K.; Oh, Y.; Klein, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

208 HGS-ETR1, a fully human monoclonal a

✍ S.J. Hotte; A.M. Oza; L.H. Le; M. MacLean; A. Iacobucci; A. Corey; N.L. Fox; H.W 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB

197 A phase I and pharmacokinetic (PK) s

✍ J. de Bono; G. Attard; R. Plummer; S. Pacey; C. Bale; L. Vidal; A. Greystoke; N. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase II trial of mapatumumab, a fully h

✍ Trarbach, T; Moehler, M; Heinemann, V; Köhne, C-H; Przyborek, M; Schulz, C; Snel 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 318 KB

Phase 2 study of mapatumumab, a fully hu

✍ Greco, F. Anthony; Bonomi, Philip; Crawford, Jeffrey; Kelly, Karen; Oh, Yun; Hal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Phase II Trial of Mapatumumab, a Fully H

✍ von Pawel, Joachim; Harvey, Jimmie H.; Spigel, David R.; Dediu, Mircea; Reck, Ma 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 569 KB